COMMUNITIES ADVANCING RESEARCH EQUITY FOR HEALTH

Dead / Abandoned — Abandoned — failure to respond (as of 28 Feb 2026)

What this means for you

This application is over — abandoned 24 Nov 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
98837649
Mark type
Stylized text
Filed
05 Nov 2024
Abandoned
24 Nov 2025
Attorney of record
Angela Y. Dai

Goods and services

  • Class 009 — Scientific and electric apparatus: Downloadable videos in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases.
  • Class 016 — Paper goods and printed matter: Printed publications in the nature of brochures and articles, all in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases.
  • Class 035 — Advertising and business services: Promoting collaboration within the scientific research, medical research, academic research, artificial intelligence (AI) research, healthcare provider, and patient communities to achieve advances in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; promoting advances in healthcare research and healthcare research methodology; promoting collaboration between the scientific research, medical research, academic research, artificial intelligence (AI) research, healthcare provider, and patient communities and underserved and vulnerable populations to achieve increased access to clinical research; promoting collaboration within the scientific research, medical research, academic research, artificial intelligence (AI) research, healthcare provider, and patient communities to achieve increased access to clinical research for underserved and vulnerable populations; promoting collaboration within the scientific, research, and healthcare communities to achieve advances in the field of health equity, namely, the absence of unfair, avoidable, or remediable healthcare differences among groups of people, whether those groups are defined socially, economically, demographically, or geographically or by other dimensions of inequality; business management of programs related to public-private partnerships in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; promoting public awareness of public-private partnerships in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; promoting the interests of public-private partnerships in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; maintaining a registry of de-identified patient data in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; recruitment of individuals to participate in research and clinical studies in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; promoting an organizational infrastructure for supporting the engagement of communities of patients, healthcare professionals, and researchers; promoting collaboration within the scientific, research, medical, and healthcare provider communities to achieve advances in the field of healthcare; promoting the exchange of information and resources within the scientific, research, medical, and healthcare provider communities to achieve advances in the field of healthcare.
  • Class 036 — Insurance and financial services: Providing grants and financial support for human biomedical research, development of diagnostic, prevention, and treatment strategies for human diseases, and clinical research and development.
  • Class 041 — Education and entertainment services: Non-downloadable videos in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; providing a website featuring educational information in the fields of human biomedical research, participating in healthcare research studies, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; providing online, non-downloadable publications in the nature of brochures, articles, blogs, social media posts, and images in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases.
  • Class 042 — Scientific and technological services: Research services, namely, human biomedical research and development and clinical research and development; providing online non-downloadable software for data integration, exchange, management, and analysis in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; data mining; providing online non-downloadable software for conducting, managing, monitoring, and participating in healthcare research studies; providing a website featuring temporary use of non-downloadable software allowing users to integrate, exchange, manage, and analyze data in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; providing a website featuring temporary use of non-downloadable software allowing users to conduct, manage, monitor, and participate in healthcare research studies; providing an on-line computer database featuring de-identified patient data in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases, all the foregoing for scientific research purposes; providing a hub for capturing, storing, sharing, transferring, exchanging, and managing data in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; providing medical and scientific research information in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases via a website and social media platforms; scientific research in the nature of conducting clinical studies for human subjects in the fields of human biomedical research, genomics, bioinformatics, human health, clinical research and development, and diagnostic, prevention, and treatment strategies for human diseases; medical and scientific research, namely, conducting clinical studies for others.

Owner

Prosecution history

  • 28 Feb 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 28 Feb 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 26 Feb 2026 — ASSIGNED TO EXAMINER
  • 15 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
  • 15 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
  • 23 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 23 May 2025 — NON-FINAL ACTION E-MAILED
  • 23 May 2025 — NON-FINAL ACTION WRITTEN
  • 04 May 2025 — ASSIGNED TO EXAMINER
  • 02 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 05 Nov 2024 — NEW APPLICATION ENTERED

View this trademark record on Marksy